Alto Neuroscience (ANRO) Shares Outstanding (Entity) (2023 - 2026)
Alto Neuroscience's Shares Outstanding (Entity) was 35.09 million in Q2 2026, up 29.6% from 27.07 million a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Alto Neuroscience (ANRO) Shares Outstanding (Entity) (2023 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Entity) at Alto Neuroscience came in at 31.92 million, up 18.3% from FY2024.
- In earlier years, Shares Outstanding (Entity) was 26.99 million in FY2024 (+604.2%) and 3.83 million in FY2023.
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2023.
- Compared with a year earlier, Shares Outstanding (Entity) has increased for ten straight quarters, with growth averaging 168.4% over the last eight quarters.
- The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.4% (Q2 2025) and 614.1% (Q2 2024) over the last five years.
- Per Business Quant data, ANRO's Shares Outstanding (Entity) in the three quarters before Q2 2026 was 35.05 million (Q1 2026), 31.92 million (Q4 2025) and 27.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Alto Neuroscience | 897.35 Mn | 897.35 Mn | - | 35.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.09 Mn |
| Mar 31, 2026 | 35.05 Mn |
| Dec 31, 2025 | 31.92 Mn |
| Sep 30, 2025 | 27.17 Mn |
| Jun 30, 2025 | 27.07 Mn |
| Mar 31, 2025 | 27.07 Mn |
| Dec 31, 2024 | 26.99 Mn |
| Sep 30, 2024 | 26.97 Mn |
| Jun 30, 2024 | 26.95 Mn |
| Mar 31, 2024 | 17.60 Mn |
| Dec 31, 2023 | 3.83 Mn |
| Sep 30, 2023 | 3.80 Mn |
| Jun 30, 2023 | 3.77 Mn |
| Mar 31, 2023 | 3.76 Mn |
API Access
Alto Neuroscience Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ANRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "ANRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ANRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();